 Antibodies
"Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
| Descriptor ID |
D000906
|
| MeSH Number(s) |
D12.776.124.486.485.114 D12.776.124.790.651.114 D12.776.377.715.548.114
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Antibodies".
- Antibodies
- Antibodies, Anti-Idiotypic
- Antibodies, Archaeal
- Antibodies, Bacterial
- Antibodies, Bispecific
- Antibodies, Blocking
- Antibodies, Catalytic
- Antibodies, Fungal
- Antibodies, Helminth
- Antibodies, Heterophile
- Antibodies, Immobilized
- Antibodies, Monoclonal
- Antibodies, Neoplasm
- Antibodies, Neutralizing
- Antibodies, Phospho-Specific
- Antibodies, Protozoan
- Antibodies, Viral
- Antigen-Antibody Complex
- Antitoxins
- Autoantibodies
- Immune Sera
- Immunoconjugates
- Immunoglobulin Allotypes
- Immunoglobulin Isotypes
- Immunoglobulins, Intravenous
- Immunoglobulins, Thyroid-Stimulating
- Insulin Antibodies
- Isoantibodies
- Oligoclonal Bands
- Opsonin Proteins
- Plantibodies
- Precipitins
- Reagins
This graph shows the total number of publications written about "Antibodies" by people in UAMS Profiles by year, and whether "Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 0 | 1 | 1 | | 2023 | 0 | 1 | 1 | | 2022 | 0 | 3 | 3 | | 2020 | 0 | 1 | 1 | | 2019 | 2 | 2 | 4 | | 2018 | 2 | 0 | 2 | | 2017 | 3 | 0 | 3 | | 2016 | 1 | 3 | 4 | | 2015 | 1 | 0 | 1 | | 2014 | 1 | 5 | 6 | | 2013 | 2 | 2 | 4 | | 2012 | 0 | 4 | 4 | | 2011 | 3 | 2 | 5 | | 2010 | 0 | 1 | 1 | | 2009 | 1 | 5 | 6 | | 2008 | 2 | 4 | 6 | | 2007 | 0 | 3 | 3 | | 2006 | 3 | 2 | 5 | | 2005 | 2 | 5 | 7 | | 2004 | 1 | 4 | 5 | | 2003 | 0 | 3 | 3 | | 2002 | 0 | 4 | 4 | | 2001 | 0 | 2 | 2 | | 2000 | 0 | 1 | 1 | | 1999 | 1 | 2 | 3 | | 1997 | 1 | 1 | 2 | | 1996 | 0 | 2 | 2 | | 1995 | 0 | 2 | 2 | | 1994 | 1 | 1 | 2 | | 1993 | 1 | 0 | 1 | | 1992 | 2 | 1 | 3 | | 1991 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies" by people in Profiles over the past ten years.
-
Sun F, Cheng Y, Wanchai V, Guo W, Mery D, Xu H, Gai D, Siegel E, Bailey C, Ashby C, Al Hadidi S, Schinke C, Thanendrarajan S, Ma Y, Yi Q, Orlowski RZ, Zangari M, van Rhee F, Janz S, Bishop G, Tricot G, Shaughnessy JD, Zhan F. Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth. Nat Commun. 2024 Jan 19; 15(1):615.
-
Lee H, Ahn S, Maity R, Leblay N, Ziccheddu B, Truger M, Chojnacka M, Cirrincione A, Durante M, Tilmont R, Barakat E, Poorebrahim M, Sinha S, McIntyre J, M Y Chan A, Wilson H, Kyman S, Krishnan A, Landgren O, Walter W, Meggendorfer M, Haferlach C, Haferlach T, Einsele H, Kort?m MK, Knop S, Alberge JB, Rosenwald A, Keats JJ, Rasche L, Maura F, Neri P, Bahlis NJ. Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma. Nat Med. 2023 09; 29(9):2295-2306.
-
Richmond ME, Deshpande SR, Zangwill SD, Bichell DP, Kindel SJ, Mahle WT, Schroder JN, Wigger MA, Knecht KR, Pahl E, Gaglianello NA, Goetsch MA, Simpson P, Dasgupta M, Zhang L, North PE, Tomita-Mitchell A, Mitchell ME. Validation of donor fraction cell-free DNA with biopsy-proven cardiac allograft rejection in children and adults. J Thorac Cardiovasc Surg. 2023 02; 165(2):460-468.e2.
-
Mock DM, Stowell SR, Franco RS, Kyosseva SV, Nalbant D, Schmidt RL, Cress GA, Strauss RG, Cancelas JA, von Goetz M, North AK, Widness JA. Antibodies against biotin-labeled red blood cells can shorten posttransfusion survival. Transfusion. 2022 04; 62(4):770-782.
-
Henrich Lobo R. Enzymatic Immunohistochemistry. Methods Mol Biol. 2022; 2422:125-129.
-
Moreno V, Smith EA, Pi?a-Oviedo S. Fluorescent Immunohistochemistry. Methods Mol Biol. 2022; 2422:131-146.
-
Kieber-Emmons T. Antibodies are the Forefront of Today's Medicine. Monoclon Antib Immunodiagn Immunother. 2021 06; 40(3):87-88.
-
Roy B, Kovvuru S, Castillo YC, Huttner A, Nowak RJ. Reply to: What is the pattern of the neuropathy associated with anti-FGFR3 antibodies? Eur J Neurol. 2020 10; 27(10):e59.
-
Banaszek A, Bumm TGP, Nowotny B, Geis M, Jacob K, W?lfl M, Trebing J, Kucka K, Kouhestani D, Gogishvili T, Krenz B, Lutz J, Rasche L, H?nemann D, Neuweiler H, Heiby JC, Bargou RC, Wajant H, Einsele H, Riethm?ller G, Stuhler G. On-target restoration of a split T cell-engaging antibody for precision immunotherapy. Nat Commun. 2019 11 26; 10(1):5387.
-
McClenahan SJ, Kormos CM, Gunnell M, Hambuchen MD, Lamb P, Carroll FI, Lewin AH, Peterson EC, Owens SM. Design, synthesis and biological evaluation of a bi-specific vaccine against a-pyrrolidinovalerophenone (a-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats. Vaccine. 2020 01 10; 38(2):336-344.
-
Figueiredo VC, Dungan CM, Peterson CA, McCarthy JJ. On the appropriateness of antibody selection to estimate mTORC1 activity. Acta Physiol (Oxf). 2020 02; 228(2):e13354.
-
Van Tine BA, Govindarajan R, Attia S, Somaiah N, Barker SS, Shahir A, Barrett E, Lee P, Wacheck V, Ramage SC, Tap WD. Incidence and Management of Olaratumab Infusion-Related Reactions. J Oncol Pract. 2019 11; 15(11):e925-e933.
-
Laubach JP, van de Donk N, Davies FE, Mikhael J. Practical Considerations for Antibodies in Myeloma. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:667-674.
-
Tamplen M, Fowler T, Markey J, Knott PD, Suva LJ, Alliston T. Treatment with anti-Sclerostin antibody to stimulate mandibular bone formation. Head Neck. 2018 07; 40(7):1453-1460.
-
Palmer BW, Harmell AL, Dunn LB, Kim SY, Pinto LL, Golshan S, Jeste DV. Multimedia Aided Consent for Alzheimer's Disease Research. Clin Gerontol. 2018 Jan-Feb; 41(1):20-32.
-
Pelletier J, Agonsanou H, Delvalle N, Fausther M, Salem M, Gulbransen B, S?vigny J. Generation and characterization of polyclonal and monoclonal antibodies to human NTPDase2 including a blocking antibody. Purinergic Signal. 2017 Sep; 13(3):293-304.
-
Schmidt RL, Mock DM, Franco RS, Cohen RM, North AK, Cancelas JA, Geisen C, Strauss RG, Vlaar AP, Nalbant D, Widness JA. Antibodies to biotinylated red blood cells in adults and infants: improved detection, partial characterization, and dependence on red blood cell-biotin dose. Transfusion. 2017 06; 57(6):1488-1496.
-
Adams R, Burnley RJ, Valenzano CR, Qureshi O, Doyle C, Lumb S, Del Carmen Lopez M, Griffin R, McMillan D, Taylor RD, Meier C, Mori P, Griffin LM, Wernery U, Kinne J, Rapecki S, Baker TS, Lawson AD, Wright M, Ettorre A. Discovery of a junctional epitope antibody that stabilizes IL-6 and gp80 protein:protein interaction and modulates its downstream signaling. Sci Rep. 2017 01 30; 7:37716.
-
Rosenbaum ER, Pandey S, Harville TO, Drobena GA, Cottler-Fox M. Flow Cytometric Panel-Reactive Antibody Results and the Ability to Find Transfusion-Compatible Platelets after Antibody-Desensitization for Allogeneic Bone Marrow Transplant. Ann Clin Lab Sci. 2016 Dec; 46(6):662-665.
-
Weinkopff T, Konradt C, Christian DA, Discher DE, Hunter CA, Scott P. Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls Disease. J Immunol. 2016 09 01; 197(5):1823-31.
-
Kilaparty SP, Agarwal R, Singh P, Kannan K, Ali N. Endoplasmic reticulum stress-induced apoptosis accompanies enhanced expression of multiple inositol polyphosphate phosphatase 1 (Minpp1): a possible role for Minpp1 in cellular stress response. Cell Stress Chaperones. 2016 07; 21(4):593-608.
-
Guo X, Hollander L, MacPherson D, Wang L, Velazquez H, Chang J, Safirstein R, Cha C, Gorelick F, Desir GV. Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer. Sci Rep. 2016 Mar 14; 6:22996.
-
Giorgakis E, Ramesh B, Kamali-Dashtarzheneh A, Fusai GK, Imber C, Tsironis D, Loizidou M. Demonstration of Calreticulin Expression in Hamster Pancreatic Adenocarcinoma with the Use of Fluorescent Gold Quantum Dots. Anticancer Res. 2016 Mar; 36(3):861-7.
-
Saha S, Murali R, Pashov A, Kieber-Emmons T. The Potential Role of Solvation in Antibody Recognition of the Lewis Y Antigen. Monoclon Antib Immunodiagn Immunother. 2015 Oct; 34(5):295-302.
-
Steplewski Z, Thurin M, Kieber-Emmons T. Antibodies: At The Nexus of Antigens and Cancer Vaccines. J Infect Dis. 2015 Jul 15; 212 Suppl 1:S59-66.
-
Chan DV, Flynn J, Ziegler R, Wong HK. HLA-DR1 in familial frontal fibrosing alopecia. J Am Acad Dermatol. 2015 Jul; 73(1):e39.
-
Gluth MB, Kaufmann YC, Dornhoffer JL, Ferguson S. Immunotargeted photodynamic therapy for cholesteatoma: in vitro results with anti-EGFR-coated indocyanine green nanocapsules. Otol Neurotol. 2015 Jan; 36(1):76-81.
-
Ronis MJ, Mercer KE, Gannon B, Engi B, Zimniak P, Shearn CT, Orlicky DJ, Albano E, Badger TM, Petersen DR. Increased 4-hydroxynonenal protein adducts in male GSTA4-4/PPAR-a double knockout mice enhance injury during early stages of alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. 2015 Mar 01; 308(5):G403-15.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|